Biotech | September 03, 2021
DGCI green lights Biological E for Phase 2/3 trials of its Covid-19 vaccine candidate for children
The trial will be conducted across 10 sites in India
The trial will be conducted across 10 sites in India
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
These vaccine doses will be manufactured and stockpiled by the company from August-December 2021
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The approval marks a major milestone in the global fight against antimicrobial resistance
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Subscribe To Our Newsletter & Stay Updated
